BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 10615666)

  • 1. [Imaging of secondary pulmonary changes in central bronchial carcinomas by F-18-FDG PET].
    Briele B; Willkomm P; Grünwald F; Ruhlmann J; Biersack HJ
    Nuklearmedizin; 1999; 38(8):323-7. PubMed ID: 10615666
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Baha A; Yildirim F; Kokturk N; Akdemir UO; Demircan S; Turktas H
    Clin Respir J; 2016 Nov; 10(6):740-745. PubMed ID: 25689088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [F-18-FDG PET for primary diagnosis differential diagnosis of pleural processes].
    Buchmann I; Guhlmann CA; Elsner K; Gfrörer W; Schirrmeister H; Kotzerke J; Buck A; Reske SN
    Nuklearmedizin; 1999; 38(8):319-22. PubMed ID: 10615665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thallium and FDG uptake by atelectasis with bronchogenic carcinoma.
    Kawabe J; Okamura T; Shakudo M; Koyama K; Wanibuchi H; Shimonishi Y; Ochi H; Yamada R
    Ann Nucl Med; 1999 Aug; 13(4):273-6. PubMed ID: 10510886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled prospective study of positron emission tomography using the glucose analogue [18f]fluorodeoxyglucose in the evaluation of pulmonary nodules.
    Präuer HW; Weber WA; Römer W; Treumann T; Ziegler SI; Schwaiger M
    Br J Surg; 1998 Nov; 85(11):1506-11. PubMed ID: 9823912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. F-18 fluorodeoxyglucose chest uptake in lung inflammation and infection.
    Bakheet SM; Saleem M; Powe J; Al-Amro A; Larsson SG; Mahassin Z
    Clin Nucl Med; 2000 Apr; 25(4):273-8. PubMed ID: 10750966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bronchogenic carcinoma associated with rheumatoid arthritis: role of FDG-PET scans.
    Rodríguez P; Romero T; Rodríguez de Castro F; Hussein M; Freixinet J
    Rheumatology (Oxford); 2006 Mar; 45(3):359-60. PubMed ID: 16436491
    [No Abstract]   [Full Text] [Related]  

  • 8. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
    Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
    Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thoracic FDG PET: state of the art.
    Erasmus JJ; McAdams HP; Patz EF; Goodman PC; Coleman RE
    Radiographics; 1998; 18(1):5-20. PubMed ID: 9460106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined fluorine-18-FDG and carbon-11-methionine PET for diagnosis of tumors in lung and mediastinum.
    Nettelbladt OS; Sundin AE; Valind SO; Gustafsson GR; Lamberg K; Långström B; Björnsson EH
    J Nucl Med; 1998 Apr; 39(4):640-7. PubMed ID: 9544671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorine-18-fluorodeoxyglucose uptake in pneumonia.
    Kapucu LO; Meltzer CC; Townsend DW; Keenan RJ; Luketich JD
    J Nucl Med; 1998 Jul; 39(7):1267-9. PubMed ID: 9669408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimodality imaging features in a case of bronchial carcinoid including FDG PET.
    Shin V; Bhargava P; Brown J; Ames ED; Kang P
    Med Sci Monit; 2007 Jan; 13(1):CS4-8. PubMed ID: 17179913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-[F-18]-2-deoxy-D-glucose.
    Patz EF; Lowe VJ; Hoffman JM; Paine SS; Harris LK; Goodman PC
    Radiology; 1994 May; 191(2):379-82. PubMed ID: 8153309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomographic imaging with fluorodeoxyglucose isefficacious in evaluating malignant pulmonary disease.
    Graeber GM; Gupta NC; Murray GF
    J Thorac Cardiovasc Surg; 1999 Apr; 117(4):719-27. PubMed ID: 10096967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should CT play a greater role in preventing the resection of granulomas in the era of PET?
    May BJ; Levsky JM; Godelman A; Jain VR; Little BP; Mahadevia PS; Burton WB; Haramati LB
    AJR Am J Roentgenol; 2011 Apr; 196(4):795-800. PubMed ID: 21427327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma.
    Delbeke D; Rose DM; Chapman WC; Pinson CW; Wright JK; Beauchamp RD; Shyr Y; Leach SD
    J Nucl Med; 1999 Nov; 40(11):1784-91. PubMed ID: 10565771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorine-18-fluorodeoxyglucose uptake in rheumatoid arthritis-associated lung disease in a patient with thyroid cancer.
    Bakheet SM; Powe J
    J Nucl Med; 1998 Feb; 39(2):234-6. PubMed ID: 9476924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of ¹⁸F-FDG uptake features in the differential diagnosis of solitary pulmonary lesions with PET/CT.
    Zhao M; Chang B; Wei Z; Yu H; Tian R; Yuan L; Jin H
    World J Surg Oncol; 2015 Sep; 13():271. PubMed ID: 26369407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Round pneumonia mimicking pulmonary malignancy on F-18 FDG PET/CT.
    Shie P; Farukhi I; Hughes RS; Oz OK
    Clin Nucl Med; 2007 Jan; 32(1):55-6. PubMed ID: 17179809
    [No Abstract]   [Full Text] [Related]  

  • 20. Regional nodal staging with 18F-FDG PET-CT in non-small cell lung cancer: Additional diagnostic value of CT attenuation and dual-time-point imaging.
    Li M; Wu N; Liu Y; Zheng R; Liang Y; Zhang W; Zhao P
    Eur J Radiol; 2012 Aug; 81(8):1886-90. PubMed ID: 21511421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.